DNA methylation data analysis and its application to cancer research.

With the rapid development of genome-wide high-throughput technologies, including expression arrays, SNP arrays and next-generation sequencing platforms, enormous amounts of molecular data have been generated and deposited in the public domain. The application of computational approaches is required to yield biological insights from this enormous, ever-growing resource. A particularly interesting subset of these resources is related to epigenetic regulation, with DNA methylation being the most abundant data type. In this paper, we will focus on the analysis of DNA methylation data and its application to cancer studies. We first briefly review the molecular techniques that generate such data, much of which has been obtained with the use of the most recent version of Infinium HumanMethylation450 BeadChip(®) technology (Illumina, CA, USA). We describe the coverage of the methylome by this technique. Several examples of data mining are provided. However, it should be understood that reliance on a single aspect of epigenetics has its limitations. In the not too distant future, these defects may be rectified, providing scientists with previously unavailable opportunities to explore in detail the role of epigenetics in cancer and other disease states.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Julie V. Harness,et al.  Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. , 2012, Cell stem cell.

[3]  W. Reik,et al.  Genomic imprinting: parental influence on the genome , 2001, Nature Reviews Genetics.

[4]  P. Munkholm,et al.  Genome‐wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases , 2012, Inflammatory bowel diseases.

[5]  S. Lam,et al.  Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression , 2012, Genome research.

[6]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[7]  G. V. van Muijen,et al.  Cancer/testis‐associated genes: Identification, expression profile, and putative function , 2003, Journal of cellular physiology.

[8]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[9]  P. Ainsworth,et al.  Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). , 1997, American journal of human genetics.

[10]  S. Baylin,et al.  DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.

[11]  Andrew P. Feinberg,et al.  Genome-scale approaches to the epigenetics of common human disease , 2009, Virchows Archiv.

[12]  Martha L. Bulyk,et al.  UniPROBE: an online database of protein binding microarray data on protein–DNA interactions , 2008, Nucleic Acids Res..

[13]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[14]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[15]  A. Viale,et al.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012, Nature.

[16]  Dan Wang,et al.  IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data , 2012, Bioinform..

[17]  J. Costello,et al.  Genome-scale DNA methylation analysis. , 2010, Epigenomics.

[18]  Dixie L Mager,et al.  Complex controls: the role of alternative promoters in mammalian genomes. , 2003, Trends in genetics : TIG.

[19]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[20]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[21]  Zhijin Wu,et al.  Accurate genome-scale percentage DNA methylation estimates from microarray data. , 2011, Biostatistics.

[22]  A. Monaco,et al.  The UTX gene escapes X inactivation in mice and humans. , 1998, Human molecular genetics.

[23]  Michael Q. Zhang,et al.  Large-scale human promoter mapping using CpG islands , 2000, Nature Genetics.

[24]  Jeffrey T Leek,et al.  Significance analysis and statistical dissection of variably methylated regions. , 2012, Biostatistics.

[25]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[26]  Alfonso Valencia,et al.  Distinct DNA methylomes of newborns and centenarians , 2012, Proceedings of the National Academy of Sciences.

[27]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[28]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[29]  Hiromu Suzuki,et al.  DNA methylation and microRNA dysregulation in cancer , 2012, Molecular oncology.

[30]  A. Feinberg,et al.  Relaxation of imprinted genes in human cancer , 1993, Nature.

[31]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[32]  I. King Jordan,et al.  On the presence and role of human gene-body DNA methylation , 2012, Oncotarget.

[33]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[34]  L. Akslen,et al.  Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  A. Simpson,et al.  The cancer/testis genes: review, standardization, and commentary. , 2004, Cancer immunity.

[36]  G. Church,et al.  Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset , 2005, Genome Biology.

[37]  Milena Krajnovic,et al.  Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value. , 2007, World journal of gastroenterology.

[38]  Martin J Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[39]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[40]  Ole Winther,et al.  JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update , 2007, Nucleic Acids Res..

[41]  Peter A. Jones,et al.  Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.

[42]  Huanming Yang,et al.  An atlas of DNA methylomes in porcine adipose and muscle tissues , 2012, Nature Communications.

[43]  P. Laird.  Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[44]  J. Ku,et al.  Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. , 2006, World journal of gastroenterology.

[45]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[46]  Andrew P. Feinberg,et al.  Epigenomics Reveals a Functional Genome Anatomy and a New Approach to Common Disease , 2010, Nature Biotechnology.

[47]  S. Baylin.  The cancer epigenome: its origins, contributions to tumorigenesis, and translational implications. , 2012, Proceedings of the American Thoracic Society.

[48]  J. Zang,et al.  P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis. , 2011, World journal of gastroenterology.

[49]  A. Oshlack,et al.  SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.

[50]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[51]  S. Horvath,et al.  Aging effects on DNA methylation modules in human brain and blood tissue , 2012, Genome Biology.

[52]  A. Feinberg,et al.  Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.

[53]  C. Nusbaum,et al.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.